HUMAN PAPILLOMAVIRUS, HUMAN-IMMUNODEFICIENCY-VIRUS, AND CERVICAL-CANCER - NEWLY RECOGNIZED ASSOCIATIONS

被引:0
作者
VERNON, SD
ICENOGLE, JP
JOHNSON, PR
REEVES, WC
机构
来源
INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY | 1992年 / 1卷 / 06期
关键词
AIDS; CERVICAL CANCER; HUMAN IMMUNODEFICIENCY VIRUS (HIV); HUMAN PAPILLOMAVIRUS (HPV); WOMENS HEALTH;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There are now sufficient data to conclude that women infected with human immunodeficiency virus (HIV) have an increased risk of human papillomavirus (HPV) infection and preinvasive stages of cervical cancer. This association is not completely due to immunosuppression. It is likely that HPV pathogenesis is altered in HIV-infected women. Preinvasive cervical neoplasia likely occurs more frequently in HIV-infected women because of several factors, including immunosuppression, viral interactions, and alterations in viral pathogenesis. As new treatments prolong the life of HIV-infected individuals, we must continue to be aware of and reactive to an increasing number of opportunistic complications of HIV infection, such as HPV infection and associated diseases.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 50 条
  • [41] Human papillomavirus vaccines for cervical cancer
    Murakami, M
    Gurski, KJ
    Steller, MA
    [J]. JOURNAL OF IMMUNOTHERAPY, 1999, 22 (03): : 212 - 218
  • [42] HUMAN PAPILLOMAVIRUS DNA AND P53 STATUS IN STAGE IB BULKY CERVICAL-CANCER
    CHEN, CA
    CHEN, TM
    WU, CC
    CHANG, CF
    HSIEH, CY
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (11) : 678 - 682
  • [43] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    [J]. PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [44] Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy
    Palefsky, JM
    [J]. CURRENT OPINION IN ONCOLOGY, 2003, 15 (05) : 382 - 388
  • [45] Genetic variations in human papillomavirus and cervical cancer outcomes
    Rader, Janet S.
    Tsaih, Shirng-Wern
    Fullin, Daniel
    Murray, Miriam W.
    Iden, Marissa
    Zimmermann, Michael T.
    Flister, Michael J.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (09) : 2206 - 2214
  • [46] AUDITORY FUNCTION IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    BIRCHALL, MA
    WIGHT, RG
    FRENCH, PD
    COCKBAIN, Z
    SMITH, SJM
    [J]. CLINICAL OTOLARYNGOLOGY, 1992, 17 (02): : 117 - 121
  • [47] COFACTORS IN THE LATENCY AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE
    CUNNINGHAMRUNDLES, S
    HILGARTNER, MW
    TARTER, TH
    KOIDE, SH
    [J]. JOURNAL OF IMMUNOLOGICAL RESEARCH, 1991, 3 (01): : 31 - 36
  • [48] HUMAN-IMMUNODEFICIENCY-VIRUS CAUSES MONONUCLEAR PHAGOCYTE DYSFUNCTION
    BALDWIN, GC
    FLEISCHMANN, J
    CHUNG, YG
    KOYANAGI, Y
    CHEN, ISY
    GOLDE, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) : 3933 - 3937
  • [49] RHEUMATOLOGICAL MANIFESTATIONS ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    TAILLAN, B
    GARNIER, G
    FERRARI, E
    FUZIBET, JG
    QUARANTA, JF
    GRATECOS, N
    DUJARDIN, P
    [J]. REVUE DU RHUMATISME, 1992, 59 (12): : 842 - 842
  • [50] PREVALENCE OF RHEUMATIC MANIFESTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    ROGEAUX, O
    FASSIN, D
    GENTILINI, M
    [J]. ANNALES DE MEDECINE INTERNE, 1993, 144 (07): : 443 - 448